INCAPTEK is a deep-tech start-up from Switzerland led by Prof. Gleb Sukhorukov from the Queen Mary University of London (UK), the inventor of programmed-shell microencapsulation and a leading scientist in nanobiotechnology.
We are an innovative start-up established by creative scientists and experts in microencapsulation and nanotechnology that operates in the field of advanced drug delivery systems and extreme-performance materials. With over 25 years of experience in micro- and nano-encapsulation of various technological complexities for a wide range of applications, our R&D team will help you solve some of the most complex challenges.


With a strong focus on innovation and access to an extensive R&D network and research institutions, we provide tailor-made advanced solutions that allow the creation of next-generation products. We continuously push technological boundaries and develop cutting-edge technologies to produce novel innovative materials for various applications.


At INCAPTEK, our goal is to continue to innovate and revolutionise the industries with novel solutions. We always think outside the box.

Olga Fontanellaz
CEO and co-founder
Olga Fontanellaz is a specialist in project management and public health. She holds an MA in International Economics from the Graduate Institute of International and Development Studies (IHEID) in Geneva. She has extensive experience in project management and implementation of multi-million-dollar grants, strategic management advice, resource mobilisation, health financing and public-private partnerships. Olga is also the President of the Swiss association Gene Learning.
Gleb Sukhorukov
CSO and co-founder
Named by the Forbes magazine among the top 10 world-known expat scientists, Gleb Sukhorukov is the inventor of layer-by-layer microencapsulation and a leading scientist in nanotechnology and drug delivery. Gleb holds a Chair in Biopolymers at the School of Engineering and Materials Science at the Queen Mary University of London. He is the author of over 400 scientific papers, which received over 30’000 citations (Hirsch index = 100) and numerous patented inventions. See more here.
Yury Moshkin
CTO and co-founder
Yury Moshkin is an internationally renowned scientist from Switzerland with over 25 years of experience in various fields of biology and nanotechnology. Yury is the author of over 50 peer-reviewed scientific papers published in top-ranking journals, such as Nature Genetics, Molecular Cell, Genes and Development, and ACS Nano. He holds a PhD in biology from the University of Geneva and a postdoc from the Erasmus Medical Centre in Rotterdam. See more here.
Chief Technical Advisor
Igor Radchenko is a long-term scientific partner and collaborator of Professor Gleb Sukhorukov. Igor is a physics specialist with extensive experience in managing life science projects and commercialising a wide range of biotechnological products. Igor is the author of over 22 scientific papers with over 2,000 citations.
Tatiana Schneider-Neureither
Business Advisor
Tatiana Schneider-Neureither is an engineer and economist with extensive experience in leading large projects in IT, business partnership strategy and public relations. She was the second-largest shareholder in SNP Schneider-Neureither & Partner SE.

We are looking for visionary investors and industrial partners to bring our innovations to the market. Our advanced technologies offer infinite applications and opportunities to innovate or improve existing products by adding new properties and benefits. We are looking forward to long-term strategic partnerships.


With our scientific expertise, creativity and unique technologies, we can develop innovative solutions to successfully bring your ideas to the market.


For more information, please CONTACT US